ANKK1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: ANKK1

NCBI ID: G255239

ANKK1

ANKK1: A Potential Drug Target Or Biomarker for Various Diseases

ANKK1 (also known as PKK2), a protein that belongs to the Pleiotrophin-like group of proteins, has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The ANKK1 protein is a 21-kDa protein that is expressed in various tissues and cells throughout the body. It is highly conserved across different species, and its structure consists of a unique combination of conserved and highly variable regions. physiological processes, including cell signaling, migration, and invasion, and has been implicated in various diseases.

One of the key functions of ANKK1 is its role in the regulation of cell proliferation and survival. It has been shown to play a negative role in the growth and survival of various cancer cells, and is often expressed in higher levels in cancer tissues compared to normal cells. Therefore, ANKK1 has potential as a drug target or biomarker for cancer treatment.

Another function of ANKK1 is its role in neurodegenerative diseases. neurodegenerative diseases are a group of disorders that are characterized by the progressive loss of neurons and their associated structures, leading to the development of various cognitive and motor deficits. ANKK1 has been shown to be involved in the regulation of neurodegenerative diseases, and has been shown to play a positive role in the progression of several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Therefore, ANKK1 has potential as a drug target or biomarker for neurodegenerative diseases.

Additionally, ANKK1 is also involved in the regulation of immune response and has been implicated in various autoimmune disorders. ANKK1 has been shown to play a role in the regulation of T cell responses, and has been shown to be involved in the development of autoimmune disorders. . Therefore, ANKK1 has potential as a drug target or biomarker for autoimmune disorders.

In conclusion, ANKK1 is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of ANKK1 in these diseases and to develop effective treatments.

Protein Name: Ankyrin Repeat And Kinase Domain Containing 1

The "ANKK1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKK1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets